Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Long-QT syndromes are heritable diseases associated with prolongation of the QT interval on an electrocardiogram and a high risk of sudden cardiac death due to ventricular tachyarrhythmia. In long-QT syndrome type 1, mutations occur in the KCNQ1 gene, which encodes the repolarizing potassium channel mediating the delayed rectifier I(Ks) current. METHODS: We screened a family affected by long-QT syndrome type 1 and identified an autosomal dominant missense mutation (R190Q) in the KCNQ1 gene. We obtained dermal fibroblasts from two family members and two healthy controls and infected them with retroviral vectors encoding the human transcription factors OCT3/4, SOX2, KLF4, and c-MYC to generate pluripotent stem cells. With the use of a specific protocol, these cells were then directed to differentiate into cardiac myocytes. RESULTS: Induced pluripotent stem cells maintained the disease genotype of long-QT syndrome type 1 and generated functional myocytes. Individual cells showed a “ventricular,” “atrial,” or “nodal” phenotype, as evidenced by the expression of cell-type–specific markers and as seen in recordings of the action potentials in single cells. The duration of the action potential was markedly prolonged in “ventricular” and “atrial” cells derived from patients with long-QT syndrome type 1, as compared with cells from control subjects. Further characterization of the role of the R190Q–KCNQ1 mutation in the pathogenesis of long-QT syndrome type 1 revealed a dominant negative trafficking defect associated with a 70 to 80% reduction in I(Ks) current and altered channel activation and deactivation properties. Moreover, we showed that myocytes derived from patients with long-QT syndrome type 1 had an increased susceptibility to catecholamine-induced tachyarrhythmia and that beta-blockade attenuated this phenotype. CONCLUSIONS: We generated patient-specific pluripotent stem cells from members of a family affected by long-QT syndrome type 1 and induced them to differentiate into functional cardiac myocytes. The patient-derived cells recapitulated the electrophysiological features of the disorder. (Funded by the European Research Council and others.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ventricle beat rates showed a positive chronotropic response over the concentration range in both the NRVM and hiPSC-CM ventricles (Fig. 3c), as expected for healthy NRVM59, hiPSC-CM60, engineered hiPSC-CM cardiac tissues16, and human patients61.”
From A tissue-engineered scale model of the heart ventricle (2018) · cites this paper as [60]
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Previous studies using iPSC-derived cardiomyocytes from type-1 LQTS patients revealed that the mutation in KCNQ1 caused potassium ion channel dysfunction resulting in sarcolemmal deficiency [5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Tumorous cell lines, although able to proliferate, are often incorporated with unwanted genetic or chromosomal abnormalities, which might induce interference to the resulting outcomes [4,5].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Models built with iPSC derivatives also demonstrate functional and phenotypic traits comparable to their human in vivo parallel [4,5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,962
Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.02.013 · Cited by 1,549
Risk Stratification in the Long-QT Syndrome
Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,459
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming
Jaenisch, R., & Young, R. (2008) · Cell · doi:10.1016/j.cell.2008.01.015 · Cited by 1,427
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Research works printed but not linked: 2
- Freund C, 2010, Neth Heart J, 18, 51
- Brunner M, 2008, J Clin Invest, 118, 2246
Cited by
Items 601–700 of 1,000
Direct Reprogramming into Desired Cell Types by Defined Factors
Ieda, M. (2013) · The Keio Journal of Medicine · doi:10.2302/kjm.2012-0017-re · Cited by 24
White, M. C., Pang, L., & Yang, X. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.05.025 · Cited by 21
Winbo, A., Ramanan, S., Eugster, E., Rydberg, A., Jovinge, S. V., Skinner, J. R., & Montgomery, J. M. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01002.2020 · Cited by 21
Current status and future prospects of patient-derived induced pluripotent stem cells
Wang, Z., Zheng, J., Pan, R., & Chen, Y. (2021) · Human Cell · doi:10.1007/s13577-021-00592-2 · Cited by 20
Hill, A. P., Perry, M., Abi‐Gerges, N., Couderc, J., Fermini, B., Hancox, J. C., Knollmann, B. C., Mirams, G. R., Skinner, J. R., Zaręba, W., et al. (2016) · The Journal of Physiology · doi:10.1113/jp272015 · Cited by 21
Amniotic Fluid Stem Cells: A Novel Source for Modeling of Human Genetic Diseases
Antonucci, I., Provenzano, M., Rodrigues, M., Pantalone, A., Salini, V., Ballerini, P., Borlongan, C. V., & Stuppia, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040607 · Cited by 20
Induced Pluripotent Stem Cells to Study Mechanisms of Laminopathies: Focus on Epigenetics
Crasto, S., & Pasquale, E. D. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00172 · Cited by 22
Gene delivery methods and genome editing of human pluripotent stem cells
Czerwińska, P., Mazurek, S., Kołodziejczak, I., & Wiznerowicz, M. (2019) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2019.01.007 · Cited by 21
Guo, J., Tian, X. Y., Barth, M., Xian, W., Ruppenthal, S., Schaefers, H., Chen, Z., Moretti, A., Laugwitz, K., & Lipp, P. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab195 · Cited by 23
Self-citationEl‐Battrawy, I., Lan, H., Cyganek, L., Maywald, L., Zhong, R., Zhang, F., Xu, Q., Lee, J., Duperrex, E., Hierlemann, A. R., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.646 · Cited by 20
Streamlining drug discovery assays for cardiovascular disease using zebrafish
Pott, A., Rottbauer, W., & Just, S. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1671351 · Cited by 20
Innovation in safety pharmacology testing
Pugsley, M. K., Towart, R., Authier, S., Gallacher, D. J., & Curtis, M. J. (2011) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2011.05.005 · Cited by 20
Atrial-specific hiPSC-derived cardiomyocytes in drug discovery and disease modeling
Gharanei, M., Shafaattalab, S., Sangha, S. S., Gunawan, M. G., Laksman, Z., Hove‐Madsen, L., & Tibbits, G. F. (2021) · Methods · doi:10.1016/j.ymeth.2021.06.009 · Cited by 21
Role of genetic testing in young patients with idiopathic atrioventricular conduction disease
Auricchio, A., Demarchi, A., Özkartal, T., Campanale, D., Caputo, M. L., Valentino, M. D., Menafoglio, A., Regoli, F. D., Facchini, M., Bufalo, A. D., et al. (2022) · EP Europace · doi:10.1093/europace/euac196 · Cited by 19
Simons, E., Loeys, B., & Alaerts, M. (2023) · Biomedicines · doi:10.3390/biomedicines11020334 · Cited by 24
Engineered Vasculature for Cancer Research and Regenerative Medicine
Nguyen, H. T., Peirsman, A., Tirpáková, Z., Mandal, K., Vanlauwe, F., Maity, S., Kawakita, S., Khorsandi, D., Herculano, R. D., Umemura, C., et al. (2023) · Micromachines · doi:10.3390/mi14050978 · Cited by 19
Modeling mutation-specific arrhythmogenic phenotypes in isogenic human iPSC-derived cardiac tissues
Maurissen, T. L., Kawatou, M., López-Dávila, V., Minatoya, K., Yamashita, J. K., & Woltjen, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-52871-1 · Cited by 19
Induced pluripotent stem cells and neurodegenerative diseases
Chen, C., & Xiao, S. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1147-9 · Cited by 19
A review of Rett syndrome (RTT) with induced pluripotent stem cells
Vellingiri, B., Dhivya, V., Mohan, G., Mohanadevi, S., Venkatesh, B., & Geetha, B. (2016) · Stem Cell Investigation · doi:10.21037/sci.2016.09.05 · Cited by 20
Stem Cell-Derived Models in Toxicology
(2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-6661-5 · Cited by 19
Cell replacement therapy is the remedial solution for treating Parkinson’s disease
Dhivya, V., & Vellingiri, B. (2017) · Stem Cell Investigation · doi:10.21037/sci.2017.06.08 · Cited by 19
Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and Safety
Meseguer-Ripolles, J., Khetani, S. R., Blanco, J. G., Iredale, M., & Hay, D. C. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0171-8 · Cited by 23
Preclinical short QT syndrome models: studying the phenotype and drug-screening
Fan, X., Yang, G., Kowitz, J., Duru, F., Saguner, A. M., Akın, İ., Zhou, X., & El‐Battrawy, I. (2021) · EP Europace · doi:10.1093/europace/euab214 · Cited by 21
Somatic Reprogramming—Above and Beyond Pluripotency
Meir, Y. J., & Li, G. (2021) · Cells · doi:10.3390/cells10112888 · Cited by 19
Advances and applications of induced pluripotent stem cells
Pietronave, S., & Prat, M. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y11-125 · Cited by 19
Neurogenin 2 enhances the generation of patient-specific induced neuronal cells
Zhao, P., Zhu, T., Lu, X., Zhu, J., & Li, L. (2015) · Brain Research · doi:10.1016/j.brainres.2015.04.027 · Cited by 19
Christiansen, M., Hedley, P. L., Theilade, J., Stoevring, B., Leren, T. P., Eschen, O., Sorensen, K. M., Tybjærg‐Hansen, A., Ousager, L. B., Pedersen, L. N., et al. (2014) · BMC Medical Genetics · doi:10.1186/1471-2350-15-31 · Cited by 19
Bayzigitov, D. R., Medvedev, S. P., Dementyeva, E. V., Афгановна, Б. С., Pokushalov, E. A., Karaskov, A. M., & Zakian, S. M. (2016) · Cardiology Research and Practice · doi:10.1155/2016/3582380 · Cited by 21
Kalra, R. S., Dhanjal, J. K., Das, M., Singh, B., & Naithani, R. (2021) · Cells · doi:10.3390/cells10102558 · Cited by 21
Song, Y., Zheng, Z., & Lian, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.889519 · Cited by 18
Chen, Y., Masbuchin, A. N., Fang, Y., Hsu, L.-W., Wu, S., Yen, C., Liu, Y.-W., Hsiao, Y., Wang, J., Rohman, M. S., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113962 · Cited by 18
iPSC-cardiomyocytes in the preclinical prediction of candidate pharmaceutical toxicity
Lee, T. Y. T., Coles, J. G., & Maynes, J. T. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1308217 · Cited by 21
The Promise of Human Induced Pluripotent Stem Cells in Dental Research
Srijaya, T. C., Pradeep, P. J., Zain, R. B., Musa, S., Kasim, N. H. A., & Govindasamy, V. (2012) · Stem Cells International · doi:10.1155/2012/423868 · Cited by 20
Transcription factor‐mediated reprogramming: epigenetics and therapeutic potential
Firas, J., Liu, X., Lim, S. M., & Polo, J. M. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.5 · Cited by 19
Wei, H., Zhang, G., Qiu, S., Lü, J., Sheng, J., Manasi, Tan, G., Wong, P., Gan, S. U., & SHIM, W. S. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050641 · Cited by 18
Zhang, X., & Morad, M. (2020) · Cell Calcium · doi:10.1016/j.ceca.2020.102244 · Cited by 18
Friedrichs, S., Malan, D., & Sasse, P. (2012) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.09.006 · Cited by 19
Tissue Contraction Force Microscopy for Optimization of Engineered Cardiac Tissue
Schaefer, J. A., & Tranquillo, R. T. (2015) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2015.0220 · Cited by 18
Modelling Long QT Syndrome With iPS Cells: Be Still, My Beating Heart …
Tiscórnia, G., Monserrat, N., & Belmonte, J. C. I. (2011) · Circulation Research · doi:10.1161/res.0b013e318216f0db · Cited by 19
Illuminating the Potential of Pluripotent Stem Cells
Rosenzweig, A. (2010) · New England Journal of Medicine · doi:10.1056/nejme1007902 · Cited by 18
Two decades of induced pluripotent stem cell research: From discovery to diverse applications
Yamanaka, S. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.02.003 · Cited by 21
Fan, X., Yang, G., Duru, F., Grilli, M., Akın, İ., Zhou, X., Saguner, A. M., & El‐Battrawy, I. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10615-0 · Cited by 17
Clark, A. P., Wei, S., Fullerton, K. E., Krogh‐Madsen, T., & Christini, D. J. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00063.2024 · Cited by 13
Concise Review: Patient-Derived Stem Cell Research for Monogenic Disorders
Qin, Y., & Gao, W. (2015) · Stem Cells · doi:10.1002/stem.2112 · Cited by 17
Laposa, R. R. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31821823f5 · Cited by 17
An Electrifying iPSC Disease Model: Long QT Syndrome Type 2 and Heart Cells in a Dish
Kamp, T. J. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.01.010 · Cited by 17
DNA Repair Mechanisms in Huntington’s Disease
Jonson, I., Ougland, R., & Larsen, E. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8409-7 · Cited by 19
Generation of Cardiomyocytes from Pluripotent Stem Cells
Nakahama, H., & Pasquale, E. D. (2014) · Methods in molecular biology · doi:10.1007/7651_2014_173 · Cited by 18
Kuusela, J., Larsson, K., Shah, D. A., Prajapati, C., & Aalto‐Setälä, K. (2017) · Biology Open · doi:10.1242/bio.024216 · Cited by 19
Modeling congenital cataract in vitro using patient-specific induced pluripotent stem cells
Lyu, D., Zhang, L., Qin, Z., Ni, S., Li, J., Lu, B., Hao, S., Tang, Q., Yin, H., Chen, Z., et al. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00171-x · Cited by 18
Zhong, R., Schimanski, T., Zhang, F., Lan, H., Hohn, A., Xu, Q., Huang, M., Liao, Z., Lin, Q., Yang, Z., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158313 · Cited by 17
Lombardi, R. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32835fb7f3 · Cited by 19
Kalra, S., Montanaro, F., & Denning, C. N. (2016) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-150133 · Cited by 18
Assessment of Cardiotoxicity With Stem Cell-based Strategies
Stoter, A. M. S., Hirt, M. N., Stenzig, J., & Weinberger, F. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.08.012 · Cited by 18
Priori, S. G. (2011) · Circulation Research · doi:10.1161/circresaha.111.253724 · Cited by 17
Modelling Human Channelopathies Using Induced Pluripotent Stem Cells: A Comprehensive Review
Müller, M., Seufferlein, T. T. W., Illing, A., & Homann, J. M. (2013) · Stem Cells International · doi:10.1155/2013/496501 · Cited by 18
Human-induced pluripotent stem cell approaches to model inborn and acquired metabolic heart diseases
Chanana, A. M., Rhee, J., & Wu, J. C. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000277 · Cited by 17
Schork, N. J., & Nazor, K. L. (2017) · Advances in genetics · doi:10.1016/bs.adgen.2017.06.001 · Cited by 20
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Zhou, R., Xu, A., Tu, J., Liu, M., Gingold, J. A., Zhao, R., & Lee, D. (2018) · Journal of Visualized Experiments · doi:10.3791/57664 · Cited by 18
Ostrominski, J. W., Yada, R. C., Sato, N., Klein, M. G., Blinova, K., Patel, D., Valadez, R., Palisoc, M., Pittaluga, S., Peng, K.-W., et al. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0019 · Cited by 16
An in silico hiPSC-Derived Cardiomyocyte Model Built With Genetic Algorithm
Akwaboah, A. D., Tsevi, B., Yamlome, P., Treat, J. A., Brucal-Hallare, M., Cordeiro, J. M., & Deo, M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.675867 · Cited by 16
Utilizing human induced pluripotent stem cells to study atrial arrhythmias in the short QT syndrome
Shiti, A., Arbil, G., Shaheen, N., Huber, I., Setter, N., & Gepstein, L. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.08.003 · Cited by 16
The genomic stability of induced pluripotent stem cells
Chen, Z., Zhao, T., & Xu, Y. (2012) · Protein & Cell · doi:10.1007/s13238-012-2922-8 · Cited by 18
Altomare, C., Pianezzi, E., Cervio, E., Bolis, S., Biemmi, V., Benzoni, P., Camici, G. G., Moccetti, T., Barile, L., & Vassalli, G. (2016) · EP Europace · doi:10.1093/europace/euw352 · Cited by 16
Induced Pluripotent Stem Cell Modeling of Gaucher’s Disease: What Have We Learned?
Santos, D., & Tiscórnia, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040888 · Cited by 17
Sogo, T., Morikawa, K., Kurata, Y., Li, P., Ichinose, T., Yuasa, S., Nozaki, D., Miake, J., Ninomiya, H., Shimizu, W., et al. (2016) · Regenerative Therapy · doi:10.1016/j.reth.2015.12.001 · Cited by 17
Nakao, S., Ihara, D., Hasegawa, K., & Kawamura, T. (2020) · European Cardiology Review · doi:10.15420/ecr.2019.03 · Cited by 17
Genetic Cardiomyopathies: The Lesson Learned from hiPSCs
My, I., & Pasquale, E. D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051149 · Cited by 15
Current methods for fabricating 3D cardiac engineered constructs
Rogozinski, N., Yanez, A., Bhoi, R., Lee, M., & Yang, H. (2022) · iScience · doi:10.1016/j.isci.2022.104330 · Cited by 15
Ismaili, D., Schulz, C., Horváth, A., Koivumäki, J. T., Mika, D., Hansen, A., Eschenhagen, T., & Christ, T. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1132165 · Cited by 16
Jehle, J., Ficker, E. K., Wan, X., Deschênes, I., Kisselbach, J., Wiedmann, F., Staudacher, I., Schmidt, C., Schweizer, P. A., Becker, R., et al. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12002 · Cited by 15
Pasquale, E. D., Song, B., & Condorelli, G. (2013) · Journal of Visualized Experiments · doi:10.3791/50429 · Cited by 17
Targeting cardiac potassium channels for state-of-the-art drug discovery
Walsh, K. B. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.983471 · Cited by 16
Friedrichs, S., Malan, D., Voß, Y., & Sasse, P. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4010102 · Cited by 16
Kano, S., Yuan, M., Cardarelli, R. A., Maegawa, G. H. B., Higurashi, N., Gaval‐Cruz, M., Wilson, A. M., Tristan, C., Kondo, M., Chen, Y., et al. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150303110300 · Cited by 15
Induced pluripotent stem cells and hepatic differentiation
Chiang, C.-H., Huo, T., Sun, C.-C., Hsieh, J.-H., Chien, Y., Lu, K., & Lee, S. (2013) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2013.07.007 · Cited by 15
Epigenetic modulations of induced pluripotent stem cells: novel therapies and disease models
Huang, C., & Wu, J. C. (2012) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2012.02.004 · Cited by 17
Averaging in vitro cardiac field potential recordings obtained with microelectrode arrays
Kujala, V. J., Jiménez, Z. C., Väisänen, J., Tanskanen, J. M. A., Kerkelä, E., Hyttinen, J., & Aalto‐Setälä, K. (2011) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2011.04.001 · Cited by 15
Chiang, C., Chang, C.-C., Huang, H., Chen, Y., Tsai, P., Jeng, S.-Y., Chung, W., Hsieh, J.-H., Huang, H., Chiou, S., et al. (2011) · BioMed Research International · doi:10.1155/2011/219060 · Cited by 16
Induced Pluripotent Stem Cells: Global Research Trends
Negoro, T., Okura, H., & Matsuyama, A. (2017) · BioResearch open access · doi:10.1089/biores.2017.0013 · Cited by 16
Proteomics in the World of Induced Pluripotent Stem Cells
Lindoso, R. S., Kasai-Brunswick, T. H., Monnerat, G., Collino, F., Carvalho, A. B., de Carvalho, A. C. C., & Vieyra, A. R. (2019) · Cells · doi:10.3390/cells8070703 · Cited by 17
Micheu, M. M., & Rosca, A. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i4.281 · Cited by 17
Horváth, A., Christ, T., Koivumäki, J. T., Prondzynski, M., Zech, A. T. L., Spohn, M., Saleem, U., Mannhardt, I., Ulmer, B. M., Girdauskas, E., et al. (2020) · Cells · doi:10.3390/cells9010253 · Cited by 15
Transcatheter Aortic-Valve Implantation for Aortic Stenosis
Newman, J., & Shimbo, D. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1013283 · Cited by 15
Imm, J. L., Kerrigan, T. L., Jeffries, A. R., & Lunnon, K. (2017) · Epigenomics · doi:10.2217/epi-2017-0076 · Cited by 14
Recent advancements of human iPSC derived cardiomyocytes in drug screening and tissue regeneration
Huang, Y., Wang, T., Lopez, M. E. U., Hirano, M., Hasan, A., & Shin, S. R. (2020) · Microphysiological Systems · doi:10.21037/mps-20-3 · Cited by 14
Li, Y., Dinkel, H., Pakalniskyte, D., Busley, A. V., Cyganek, L., Zhong, R., Zhang, F., Xu, Q., Maywald, L., Aweimer, A., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1130 · Cited by 14
Singh, M. K., & Thase, M. E. (2025) · CNS Spectrums · doi:10.1017/s1092852925000094 · Cited by 16
Novak, A., Lorber, A., Itskovitz‐Eldor, J., & Binah, O. (2012) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10086 · Cited by 17
ProspectiveIn VitroModels of Channelopathies and Cardiomyopathies
Kawaguchi, N., Hayama, E., Furutani, Y., & Nakanishi, T. (2012) · Stem Cells International · doi:10.1155/2012/439219 · Cited by 14
Screening Action Potentials: The Power of Light
Kaestner, L., & Lipp, P. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00042 · Cited by 14
Sequiera, G. L., Mehta, A. K., Ooi, T. H., & SHIM, W. S. N. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.10.020 · Cited by 14
Wang, Z., Wang, L., Liu, W., Hu, D., Gao, Y., Ge, Q., Liu, X., Li, L., Wang, Y., Wang, S., et al. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101483 · Cited by 14
Loya, K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386882-4.00011-6 · Cited by 16
Enhancing iPSC‐CM Maturation Using a Matrigel‐Coated Micropatterned PDMS Substrate
Jiménez‐Vázquez, E. N., Jain, A., & Jones, D. K. (2022) · Current Protocols · doi:10.1002/cpz1.601 · Cited by 15
Maizels, L., Heller, E., Landesberg, M., Glatstein, S., Huber, I., Arbel, G., Gepstein, A., Aronson, D., Sharabi, S., Beinart, R., et al. (2024) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.123.012278 · Cited by 14
Odedra, D., Chiu, L. L. Y., Reis, L. A., Rask, F., Chiang, K., & Radisic, M. (2010) · Springer eBooks · doi:10.1007/978-3-7091-0385-2_15 · Cited by 14
Induced Pluripotent Stem Cells: How They Will Change the Practice of Cardiovascular Medicine
Wong, W. T., Sayed, N., & Cooke, J. P. (2013) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-9-4-206 · Cited by 16
Kuusela, J., Kim, J., Räsänen, E., & Aalto‐Setälä, K. (2016) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9686-0 · Cited by 17
Stoichiometry of the Slow Iks Potassium Channel in Human Embryonic Stem Cell-Derived Myocytes
Wang, M., & Kass, R. S. (2012) · Pediatric Cardiology · doi:10.1007/s00246-012-0255-2 · Cited by 14
Metadata
- Authors
- Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., Seyfarth, M., Sinnecker, D., Schömig, A., & Laugwitz, K.-L.
- Affiliations
- TUM Klinikum (DE)
- Deutsches Herzzentrum München (DE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-10-07
- Volume
- 363
- Issue
- 15
- Pages
- 1397-1409
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2104996733
- Cited by
- 1,251
- References
- 40
- Citations by year
- 2026: 26 · 2025: 26 · 2024: 43 · 2023: 49 · 2022: 51 · 2021: 79 · 2020: 56 · 2019: 69 · 2018: 69 · 2017: 89 · 2016: 90 · 2015: 111 · 2014: 90 · 2013: 116 · 2012: 143
- FWCI
- 88.47
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- LQT1, KCNQ1, induced pluripotent stem cells, patient-specific disease models, cardiomyocyte differentiation, action potential prolongation, delayed rectifier potassium current, beta-adrenergic blockade, sudden cardiac death, ventricular repolarization
- MeSH terms
- Kruppel-Like Factor 4, Action Potentials, Adrenergic beta-Antagonists, Adult, Aged, Cardiotonic Agents, Child, Female, Fibroblasts, Humans, Isoproterenol, Male, Pedigree, Phenotype, Potassium Channels, Gene Expression, Mutation, Missense, Reverse Transcriptase Polymerase Chain Reaction, Potassium Channel Blockers, Romano-Ward Syndrome, Myocytes, Cardiac, KCNQ1 Potassium Channel, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.